Taken together, our findings suggest that an NFκB + cell population can be found in untreated primary ER + breast tumors prior to ET, as well as in metastatic ER + PDXs, and that the preexistence of these cells is predictive of disease relapse. The gene discussed is NFKB1; the disease is breast neoplasm.